Scarica l'app Stockscreener
220.91
2.51%
5.40
Charles River Laboratories International Inc Borsa (CRL) Ultime notizie
Charles River Laboratories (CRL) Announces Leadership Transition - GuruFocus
Charles River Laboratories announces CEO transition, Girshick to succeed Foster - Investing.com UK
Charles River Labs Announces CEO Succession and Leadership Changes - TipRanks
Charles River Labs (CRL) plans CEO succession and new board role for Foster - Stock Titan
What Makes Charles River Laboratories (CRL) an Investment Bet? - MSN
Why Charles River Laboratories International Inc. stock stays resilientJuly 2025 Rallies & Reliable Trade Execution Plans - ulpravda.ru
Precision Trading with Charles River Laboratories International Inc. (CRL) Risk Zones - Stock Traders Daily
How Charles River Laboratories International Inc. stock compares to growth peersJuly 2025 Final Week & Community Consensus Trade Signals - ulpravda.ru
Will Charles River Laboratories International Inc. stock gain from lower inflationNew Guidance & Daily Chart Pattern Signal Reports - ulpravda.ru
Charles River Labs CEO to retire after more than three decades - NBC Boston
Charles River Laboratories Names Birgit Girshick CEO - citybiz
Charles River Laboratories appoints Birgit Girshick as CEO following James Foster's retirement - MSN
Can Charles River Laboratories International Inc. stock reach $100 price target2025 Market Outlook & AI Driven Price Predictions - ulpravda.ru
Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes - MarketScreener
What catalysts could drive Charles River Laboratories International Inc. stock higherMarket Movement Recap & Expert Verified Stock Movement Alerts - ulpravda.ru
Charles River Labs CEO to retire in 2026 after 30+ years at the helm - The Business Journals
Why Charles River Laboratories International Inc. stock is favored by pension funds2025 Technical Patterns & Weekly High Return Forecasts - ulpravda.ru
Charles River Laboratories International, Chair, President, CEO James Foster to Retire - MarketScreener
Charles River Laboratories announces planned retirement of James C. Foster - MarketScreener
Charles River CEO Jim Foster to retire in May 2026 after 50-year career - Investing.com Canada
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan - Business Wire
Portfolio Recap: Is Charles River Laboratories International Inc RV6 stock a top pick for value investorsMarket Risk Analysis & High Accuracy Trade Alerts - moha.gov.vn
Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue? - sharewise.com
What Makes Charles River (CRL) a New Buy Stock - Yahoo Finance
Charles River Laboratories stock hits 52-week high at $205.55 By Investing.com - Investing.com Nigeria
Charles River Laboratories International Insiders Placed Bullish Bets Worth US$1.25m - Yahoo Finance
Charles River Laboratories International (NYSE:CRL) Hits New 1-Year HighHere's Why - MarketBeat
Charles River Laboratories stock hits 52-week high at $205.55 - Investing.com India
Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Allspring Global Investments Holdings LLC Sells 113,185 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. $CRL Shares Purchased by Boston Trust Walden Corp - MarketBeat
Charles River Laboratories Stock Tests Investor Patience as Biopharma Recalibrates - AD HOC NEWS
Charles River Laboratories International (NYSE:CRL) Reaches New 52-Week HighTime to Buy? - MarketBeat
Charles River Laboratories International, Inc. $CRL Stake Cut by Norris Perne & French LLP MI - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Charles River Laboratories International Earnings Notes - Trefis
Risk Report: Why analysts raise outlook for Charles River Laboratories International Inc. stockRecession Risk & AI Forecast for Swing Trade Picks - moha.gov.vn
Animal Model Market Strategic Insights, Industry Trends, Size, - openPR.com
Corient Private Wealth LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International (NYSE:CRL) Shares Gap UpHere's What Happened - MarketBeat
Backbone of Discovery: A Deep Dive into Charles River Laboratories (CRL) - FinancialContent
Charles River Laboratories (CRL): Valuation Check After SEC Clearance and BofA Upgrade Lift the Stock - simplywall.st
Contact Us – Inside INdiana BusinessBackbone of Discovery: A Deep Dive into Charles River Laboratories (CRL) - FinancialContent
Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break - MSN
Is Charles River Laboratories stock underperforming the Dow? - MSN
Why Charles River Laboratories (CRL) Stock Is Trading Up Today - FinancialContent
Charles River Laboratories International (NYSE:CRL) Hits New 52-Week HighTime to Buy? - MarketBeat
Charles River Laboratories stock hits 52-week high at $200.96 - Investing.com
Charles River Laboratories stock hits 52-week high at $200.96 By Investing.com - Investing.com South Africa
Riverbridge Partners LLC Sells 8,323 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Thrivent Financial for Lutherans Acquires 20,172 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Assenagon Asset Management S.A. Trims Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Can Charles River Laboratories International Inc. stock hold up in economic slowdownJuly 2025 Levels & Precise Swing Trade Alerts - Улправда
Can Charles River Laboratories International Inc. (RV6) stock sustain institutional flowsWeekly Earnings Recap & Intraday High Probability Setup Alerts - Улправда
1.12%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):